Scarica l'app Stockscreener
5.39
2.28%
0.12
Dopo l'orario di chiusura:
5.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FHTX Giù?
Forum
Previsione
Precedente Chiudi:
$5.27
Aprire:
$5.29
Volume 24 ore:
37,319
Relative Volume:
0.32
Capitalizzazione di mercato:
$304.70M
Reddito:
$34.16M
Utile/perdita netta:
$-98.43M
Rapporto P/E:
-2.3034
EPS:
-2.34
Flusso di cassa netto:
$-119.33M
1 W Prestazione:
+7.58%
1M Prestazione:
+4.86%
6M Prestazione:
+22.78%
1 anno Prestazione:
-32.37%
Intervallo 1D:
$5.14
$5.40
Intervallo di 1 settimana:
$4.90
$5.4573
Portata 52W:
$2.9448
$10.25
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Nome
Foghorn Therapeutics Inc
Settore
Industria
Telefono
617-586-3100
Indirizzo
500 TECHNOLOGY SQUARE, CAMBRIDGE
Confronta FHTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
5.39 | 298.48M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-23 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-01-30 | Iniziato | B. Riley Securities | Buy |
| 2024-09-03 | Iniziato | Jefferies | Buy |
| 2024-08-19 | Iniziato | Evercore ISI | Outperform |
| 2023-03-28 | Iniziato | BofA Securities | Buy |
| 2023-01-05 | Iniziato | BMO Capital Markets | Outperform |
| 2021-11-22 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-17 | Iniziato | Cowen | Outperform |
| 2020-11-17 | Iniziato | Goldman | Buy |
| 2020-11-17 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-17 | Iniziato | Wedbush | Outperform |
Mostra tutto
Foghorn Therapeutics Inc Borsa (FHTX) Ultime notizie
Does Foghorn Therapeutics Inc. have high return on assetsJuly 2025 Movers & AI Enhanced Execution Alerts - khodrobank.com
What’s the analyst consensus on Foghorn Therapeutics Inc.Rate Hike & Daily Profit Focused Screening - khodrobank.com
Is Foghorn Therapeutics Inc. a speculative investmentEarnings Recap Summary & Weekly High Potential Stock Alerts - khodrobank.com
Is Foghorn Therapeutics Inc. trending in predictive chart modelsMarket Performance Recap & AI Optimized Trading Strategy Guides - Newser
How to build a custom watchlist for Foghorn Therapeutics Inc.2025 Big Picture & High Conviction Buy Zone Picks - Newser
Foghorn Therapeutics Inc. stock prediction for this weekAnalyst Downgrade & Smart Allocation Stock Tips - Newser
What the charts say about Foghorn Therapeutics Inc. todayExit Point & Reliable Price Breakout Alerts - Newser
Value Recap: Does Foghorn Therapeutics Inc. stock benefit from AI growthJuly 2025 Momentum & Weekly Watchlist for Consistent Profits - khodrobank.com
Price action breakdown for Foghorn Therapeutics Inc.July 2025 Breakouts & Technical Buy Zone Confirmations - Newser
Does Foghorn Therapeutics Inc. stock benefit from AI growth2025 Trade Ideas & Weekly Market Pulse Updates - khodrobank.com
Backtesting results for Foghorn Therapeutics Inc. trading strategiesQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - Newser
Trend analysis for Foghorn Therapeutics Inc. this week2025 Key Lessons & Safe Investment Capital Preservation Plans - Newser
How did FHTX's Q4 2024 earnings surprise impact investor confidence? - AInvest
What earnings revisions data tells us about Foghorn Therapeutics IncEarnings Risk Report & AI Forecast Swing Trade Picks - Newser
What earnings revisions data tells us about Foghorn Therapeutics Inc.Weekly Trend Report & Proven Capital Preservation Tips - Newser
AI Indicators Detect Buy Opportunity in Foghorn Therapeutics Inc.July 2025 Movers & Technical Confirmation Alerts - beatles.ru
Combining price and volume data for Foghorn Therapeutics Inc.Market Performance Summary & Precise Swing Trade Alerts - Newser
Heatmap analysis for Foghorn Therapeutics Inc. and competitors2025 Market Overview & Free Accurate Trade Setup Notifications - Newser
Foghorn Therapeutics Advances in Precision Therapeutics - TipRanks
Using RSI to spot recovery in Foghorn Therapeutics Inc.2025 Market Sentiment & Smart Investment Allocation Tips - Newser
Has Foghorn Therapeutics Inc. found a price floorQuarterly Trade Summary & Daily Entry Point Alerts - Newser
Is Foghorn Therapeutics Inc. a good ESG investmentJuly 2025 Price Swings & Low Drawdown Trading Strategies - khodrobank.com
Uveal Melanoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Novartis, Foghorn Therapeutics Inc., TriSalus Life Sciences, Inc., AstraZeneca - The Globe and Mail
Does Foghorn Therapeutics Inc. have pricing powerLayoff News & Technical Buy Zone Confirmation - khodrobank.com
How to track smart money flows in Foghorn Therapeutics Inc.Weekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser
Foghorn Therapeutics Inc. stock trend forecastPortfolio Value Report & Safe Entry Momentum Tips - Newser
When is the best time to exit Foghorn Therapeutics Inc.July 2025 Volume & Fast Exit and Entry Strategy Plans - Newser
Is Foghorn Therapeutics Inc. vulnerable to short sellers2025 Price Momentum & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Can Foghorn Therapeutics Inc. expand into new marketsJuly 2025 Rallies & AI Enhanced Execution Alerts - khodrobank.com
Ranking Foghorn Therapeutics Inc. among high performing stocks via toolsJuly 2025 Catalysts & Weekly Momentum Picks - Newser
Can Foghorn Therapeutics Inc. stock double in the next yearWeekly Stock Recap & Expert Approved Trade Ideas - khodrobank.com
Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's What You Should Know - Yahoo Finance
Real time social sentiment graph for Foghorn Therapeutics Inc.Earnings Summary Report & High Yield Equity Trading Tips - Newser
Predicting Foghorn Therapeutics Inc. trend using moving averages2025 Sector Review & Proven Capital Preservation Methods - Newser
How sentiment analysis helps forecast Foghorn Therapeutics Inc.July 2025 Spike Watch & Community Consensus Trade Signals - Newser
Does Foghorn Therapeutics Inc. fit your quant trading modelRate Cut & Weekly High Potential Stock Alerts - Newser
Foghorn Therapeutics Inc. stock outlook for YEARQuarterly Profit Report & Reliable Trade Execution Plans - Newser
Forecasting Foghorn Therapeutics Inc. price range with options data2025 Price Targets & Long-Term Capital Growth Strategies - Newser
Real time pattern detection on Foghorn Therapeutics Inc. stockDay Trade & Real-Time Market Trend Scan - Newser
Will earnings trigger a reversal in Foghorn Therapeutics Inc.2025 Retail Activity & Accurate Buy Signal Notifications - Newser
Foghorn Therapeutics Inc Azioni (FHTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Foghorn Therapeutics Inc Azioni (FHTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Costa Carlos | Chief People Officer |
Sep 23 '24 |
Option Exercise |
3.72 |
857 |
3,188 |
857 |
| Costa Carlos | Chief People Officer |
Sep 20 '24 |
Sale |
10.04 |
35,756 |
358,990 |
0 |
| Costa Carlos | Chief People Officer |
Sep 23 '24 |
Sale |
10.17 |
857 |
8,716 |
0 |
| Costa Carlos | Chief People Officer |
Sep 18 '24 |
Option Exercise |
3.72 |
11,574 |
43,055 |
11,574 |
| Costa Carlos | Chief People Officer |
Sep 18 '24 |
Sale |
10.05 |
11,574 |
116,319 |
0 |
| Costa Carlos | Chief People Officer |
Sep 17 '24 |
Option Exercise |
3.72 |
10,272 |
38,212 |
10,272 |
| Costa Carlos | Chief People Officer |
Sep 16 '24 |
Option Exercise |
3.72 |
400 |
1,488 |
400 |
| Costa Carlos | Chief People Officer |
Sep 17 '24 |
Sale |
10.04 |
10,272 |
103,131 |
0 |
| Costa Carlos | Chief People Officer |
Sep 16 '24 |
Sale |
10.00 |
400 |
4,000 |
0 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):